Avi Pelossof

CIK: 0001293460

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NEOG

NEOGEN CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

NEOG
NEOGEN CORP
Oct 1, 2026
Award(A)
Direct
9.8K shares at avg. $12.24$120K
NEOG
NEOGEN CORP
Oct 24, 2025
Award(A)
Direct
19.4K shares at avg. $6.19$120K

		Type	Shares	Price		Ownership
Oct 1, 2026	NEOG NEOGEN CORP	Award(A)	9,804	$12.24	$120,001	Direct
Oct 24, 2025	NEOG NEOGEN CORP	Award(A)	19,386	$6.19	$119,999	Direct

1-2 of 2 transactions

About Pelossof Avi

Pelossof Avi (SEC CIK 0001293460) files insider reports with the SEC as Director of NEOGEN CORP (NEOG).

Signal8 holds 3 ownership filings by Pelossof Avi (1 Form 3, 2 Form 4), filed between Oct 28, 2025 and Oct 2, 2026. Those filings report 2 transactions, from Oct 24, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Pelossof Avi's filings is in LANSING, MI.

Recent filings by Pelossof Avi

Oct 1, 2026: Grant or award of NEOG shares (Form 4, code A).
Oct 24, 2025: Grant or award of NEOG shares (Form 4, code A).

Other insiders filing for NEOGEN CORP (NEOG)

Freels Joe B, Chief Commercial Officer
Hastings Gregory S, VP, Animal Health
Woteki Catherine E, Director
RODRIGUEZ RAFAEL A, Director
Burke Kevin M, Chief HR Officer
Gupta Aashima, Director

How to read Form 4 transaction codes